QMP - Super Albumin Technology скачать в хорошем качестве

QMP - Super Albumin Technology

A novel biomedical technology that enhances half-life and mucosal delivery The therapeutic utility of many protein-based biologics is hampered by poor pharmacokinetics. Also, many of biologics that reach the market require frequent administration, which is a burden for the patients, their families and the healthcare system. Thus, there is an unmet need for rational molecular design that improves serum persistence and bio-distribution. There is also an unmet need for needle-free delivery of protein-based biologics across mucosal barriers, but the efficiency of unassisted transmucosal transport is very poor. Improvements will allow for less frequent drug administration, increased patient compliance, and the biologics may be more cost-effective. Scientists at University of Oslo and Oslo University Hospital, in collaboration with international researchers in Italy, Germany and US, have developed a biomedical technology that solves these major challenges.